Integra Lifesciences Holdings (IART) Cash from Operations (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Cash from Operations of 22802000.0 for Q2 2026, up 132.6% sequentially from 9803000.0 in Q1 2026, and up 155.66% YoY from 8919000.0 in Q2 2025.
Integra Lifesciences Holdings (IART) Cash from Operations (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Cash from Operations for 18 years, with the latest figure at 22802000.0 in Q2 2026.
- Quarterly Cash from Operations rose 155.66% year-over-year to 22802000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 85327000.0 (up 20.37% YoY) and the FY2025 annual result came in at 50384000.0, down 61.06% from the prior year.
- Cash from Operations climbed to 22802000.0 in Q2 2026 per IART's latest filing, from 9803000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 85334000.0 in Q4 2022 and troughed at 11257000.0 in Q1 2025.
- A 5-year average of 34266388.89 and a median of 27524500.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations plunged 171.45% in 2025, then soared 187.08% in 2026.
- Over 5 years, Cash from Operations stood at 85334000.0 in 2022, then tumbled by 31.15% to 58750000.0 in 2023, then fell by 13.63% to 50740000.0 in 2024, then sank by 76.71% to 11816000.0 in 2025, then soared by 92.98% to 22802000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 22802000.0, 9803000.0, and 11816000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.30 Bn | 1.02 Bn | 219.74 Mn | 22.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.80 Mn |
| Jun 30, 2026 | 22.80 Mn |
| Mar 31, 2026 | 9.80 Mn |
| Mar 31, 2026 | 9.80 Mn |
| Dec 31, 2025 | 11.82 Mn |
| Dec 31, 2025 | 11.82 Mn |
| Sep 30, 2025 | 40.91 Mn |
| Sep 30, 2025 | 40.91 Mn |
| Jun 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 8.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 50.74 Mn |
| Dec 31, 2024 | 50.74 Mn |
| Sep 30, 2024 | 22.49 Mn |
| Sep 30, 2024 | 22.49 Mn |
| Jun 30, 2024 | 40.40 Mn |
| Jun 30, 2024 | 40.40 Mn |
| Mar 31, 2024 | 15.76 Mn |
| Mar 31, 2024 | 15.76 Mn |